The National Center for Global Health and Medicine and Clinical Research Malaysia have signed a Memorandumof Understanding (MOU) for clinical research cooperation.
~ Expanding Clinical Research in Malaysia~
December 5th
NCGM, Center for Clinical Sciences
The Memorandum of Understanding (MOU) between National Center for Global Health and Medicine（NCGM） and the Clinical Research Malaysia (CRM) was signed on 14th October at the CRM Connect Trials
Conference in Kuala Lumpur Malaysia. Both parties expect to collaborate for clinical research through ARO Alliance
for ASEAN and East Asia (ARISE). The president of NCGM, Dr. Norihiro Kokudo, attended the event virtually,while Dr. Iiyama, the Director of the Department of International Trials (DIT), CCS was present in person to witness
the signing. From the CRM, Dr. Akhmal Yusof, the Director, signed the MOU. The event was also attended by theMinister of Health of Malaysia, Mr. Khairy Jamaluddin, and the ambassador of Japan for Malaysia, Mr. KatsuhikoTakahashi. It was a rather special event for Malaysia and Japan's collaboration in clinical research.
During the event, DIT participated in the Clinical Research Malaysia (CRM) Connect Trials Conference inKuala Lumpur Malaysia, held on 14th-15th October. Dr. Iiyama presented ARISE activities in the conference andDIT opened the exhibit boot to introduce its international clinical research projects. The Minister of Health ofMalaysia and ambassador Takahashi visited the booth and were introduced to NCGM and ARISE network activities.
Through this exhibit, we could introduce DIT’s activities to many international participants, including academia,industries, and clinical research organizations. Taking advantage of these encounters, we are further extending ourinternational collaborations for Singapore and so on.

President Kokudo, Ex-Minister of Health, Prof. Yusof,Dr. Iiyama, Ex-Minister of MOH, Ambassador at the NCGM

Dr.Iiyama, Ambassador TakahashiboothDr. Iiyama presented ARISE

Ms. Sonoda and Ms. Siburian visited CRM

On Monday, 17th October, DIT also had the opportunity to visit the CRM headquarter and the Universityof Malaya Medical Center (UMMC). At the CRM headquarter, DIT could observe the operation of its clinical researchsupport and deepen more understanding of clinical trials conduct in Malaysia. CRM operates under the Ministry ofhealth of Malaysia to facilitate the clinical trial conduct at the public hospitals of Malaysia. Recently it has completed
its Phase 1 Realisation Project (P1RP) that ensures the readiness of Malaysia for First-in-Human trials. In 2021, 215
sponsored trials had gained ethical approval, which is the highest number reported in the last eight years. Around
45% of the sponsored studies are conducted at the MOH facilities.
UMMC is the leading Academic Research Organization (ARO) for clinical research in Malaysia and has
been involved in clinical research over 20 years. It operates under the Ministry of Higher Education of Malaysia andhas an advanced clinical research unit. It is also working closely with CRM. Like CRM, UMMC has been involvedin nearly 300 clinical trials last year. UMMC is interested in joining ARISE, the NCGM-led ARO network for clinicalresearch in Asia. Collaborations with CRM and UMMC Malaysia will surely strengthen the clinical trials network
among ASEAN and East Asia countries.

Clinical Research Malaysia

Ms. Sonoda and Ms. Siburian visited UMMC